SAN LUIS OBISPO, California--(BUSINESS WIRE)--FzioMed, Inc. today announced that the company’s Laresse® dermal filler has received regulatory approval in Australia from the Therapeutic Goods Administration (TGA). The TGA is the government agency responsible for regulating drugs and medical devices in Australia.
